These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32539490)

  • 1. HIV-1 Genetic Diversity and High Prevalence of Pretreatment Drug Resistance in Tianjin, China.
    Zeng R; Ren D; Gong X; Wei M; Gao L; Yu A; Zhang D; Mi Y; Ma P
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):852-861. PubMed ID: 32539490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
    Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
    BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.
    Liu L; Dong A; Liao L; Feng Y; Shao Y; Liang S; Ruan Y; Xing H
    Curr HIV Res; 2019; 17(6):441-451. PubMed ID: 31778107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China.
    Liu M; He XQ; Deng RN; Tang SQ; Harypursat V; Lu YQ; He K; Huo Q; Yang HH; Liu Q; Chen YK
    HIV Med; 2022 Mar; 23 Suppl 1(Suppl 1):95-105. PubMed ID: 35293098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular transmission network analysis reveals the challenge of HIV-1 in ageing patients in China: elderly people play a crucial role in the transmission of subtypes and high pretreatment drug resistance in developed Eastern China, 2019-2023.
    Cao D; Xing H; Feng Y; He T; Zhang J; Ling J; Chen J; Zhao J
    Virol J; 2024 Aug; 21(1):199. PubMed ID: 39187869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Diversity and Characteristics of Drug Resistance Among Treatment-Naive People Living with HIV in Xi'an, China.
    Xia H; Jin J; Ba H; Zhang Y; Li J; Guo R; Li Y; Ma P; Zhang Y
    Drug Des Devel Ther; 2023; 17():1485-1494. PubMed ID: 37220545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Drug Resistance and Genetic Transmission Networks Among Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Antiretroviral Therapy Failure in Guangxi, China.
    Yu D; Liang B; Yang Y; Liu J; Liang H; Zhang F; Jiang J; Huang J; Zhong S; Qin C; Jiang J; Liang H; Ye L
    AIDS Res Hum Retroviruses; 2022 Oct; 38(10):822-830. PubMed ID: 35972723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HIV-1 Drug-Resistance Genotypes Among Unique Recombinant Forms from Yunnan Province, China in 2016-2017.
    Deng X; Liu J; Li J; Yang B; Shu Y; Zhang M; Dong X
    AIDS Res Hum Retroviruses; 2020 May; 36(5):389-398. PubMed ID: 31914782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Subtype Diversity and Factors Affecting Drug Resistance among Patients with Virologic Failure in Antiretroviral Therapy in Hainan Province, China, 2014-2020.
    Yu E; Xu YJ; Li M; Yang Y; Liang HY; Zhong SM; Qin C; Lan YN; Li DW; Yu JP; Pang Y; Qin XQ; Liang H; Zhu KK; Ye L; Liang BY
    Biomed Environ Sci; 2023 Sep; 36(9):800-813. PubMed ID: 37803893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China.
    Zhang J; Guo Z; Yang J; Pan X; Jiang J; Ding X; Zhang W; Xia Y; Xu Y; Huang J
    J Med Virol; 2015 Oct; 87(10):1668-76. PubMed ID: 25899877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China.
    Zhou C; Liang S; Li Y; Zhang Y; Li L; Ye L; Yuan D; Su L
    BMC Infect Dis; 2022 Jul; 22(1):602. PubMed ID: 35799101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 pretreatment drug resistance and genetic transmission network in the southwest border region of China.
    Li D; Chen H; Li H; Ma Y; Dong L; Dai J; Jin X; Yang M; Zeng Z; Sun P; Song Z; Chen M
    BMC Infect Dis; 2022 Sep; 22(1):741. PubMed ID: 36117159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study.
    Lan Y; Li L; He X; Hu F; Deng X; Cai W; Li J; Ling X; Fan Q; Cai X; Li L; Li F; Tang X
    Virol J; 2021 Sep; 18(1):181. PubMed ID: 34488793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of virus gene subtypes and drug resistance monitoring results of newly reported HIV/AIDS population in Anhui Province from 2020 to 2023].
    Qin YZ; Shen YL; Liu AW; Wu JJ; Miu LF; Fang Q; Shuai CX; Jin L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Aug; 58(8):1204-1212. PubMed ID: 39142890
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased prevalence of pretreatment drug resistance mutations in treatment-naïve people living with HIV-1 in Henan Province, China (2022/23).
    Liu J; Liu C; Wang Y; Wei S; Ma J; Li Y; Chen X; Zhao Q; Huo Y
    Infect Genet Evol; 2023 Nov; 115():105520. PubMed ID: 37898414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017.
    Yuan D; Du Z; Zhou J; Ye L; Su L; Yang H; Yuan F; Li Y; Liu H; Zhai W; Liang S; Yang S
    Medicine (Baltimore); 2019 Oct; 98(43):e17585. PubMed ID: 31651864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia.
    Kiros M; Alemayehu DH; Geberekidan E; Mihret A; Maier M; Abegaz WE; Mulu A
    Retrovirology; 2020 Sep; 17(1):33. PubMed ID: 32993693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV-1 drug resistance and subtypes in newly reported HIV/AIDS patients before antiretroviral therapy in Taizhou city, 2016-2018].
    Xu LL; Shen WW; Chen XX; Li GX; Xu YY; Gao MY; Zhou SJ; Lin HJ; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Apr; 42(4):711-715. PubMed ID: 34814456
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries.
    Kirichenko A; Kireev D; Lopatukhin A; Murzakova A; Lapovok I; Saleeva D; Ladnaya N; Gadirova A; Ibrahimova S; Safarova A; Grigoryan T; Petrosyan A; Sarhatyan T; Gasich E; Bunas A; Glinskaya I; Yurovsky P; Nurov R; Soliev A; Ismatova L; Musabaev E; Kazakova E; Rakhimova V; Pokrovsky V
    PLoS One; 2022; 17(1):e0257731. PubMed ID: 35061671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.